Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis

Interleukin-1 receptor antagonist (IL-1Ra) is an endogenous inhibitor of in terleukin-l. The expression of IL-1Ra and interleukin-1 alpha (IL-1 alpha) was measured in murine epidermis after treatment with tumor promoters and i n tumor cell lines. A single treatment with three different tumor promoters (12-O-tetradecanoylphorbol-13-acetate (TPA), anthralin, and thapsigargin) induced IL-1Ra mRNA with different kinetics in mouse skin. The expression o f IL-1Ra mRNA also was induced by TPA and IL-1 alpha in a dose-related and time-dependent manner in cultured mouse keratinocytes. Expression of IL-1Ra mRNA peaked 6 h after treatment. Both IL-1Ra and IL-1 alpha protein a nd I L-1Ra and IL-1 alpha mRNA were measured in various keratinocyte tumor cell lines (C50, MT1/2, HEL30, JWF2, CH72, and BPCC2). The expression of IL-1 al pha was increased in papilloma and squamous cell carcinoma cell lines. IL-1 Ra protein also was increased in nontumorigenic and papilloma cell lines; h owever, the expression was dramatically reduced in some carcinoma cell line s. Finally, we detected IL-1 alpha and IL-1Ra protein in mouse skin tumors by western blot analysis, and localization was assessed by immunohistochemi cal analysis. Positive staining for both IL-1 alpha and IL-1Ra was observed in the cytoplasm and was most prominent in the suprabasal layer. Although IL-1Ra protein increased in papillomas and carcinomas, IL-1 alpha protein w as not significantly increased above basal level in most tumors. (C) 1999 W iley-Liss, Inc.